
Rapid oral 1: GI tumours, upper digestive cancers
Prof Jean-Luc Van Laethem reviews highlights from the ESMO 2026 Rapid Oral 1 session on upper gastrointestinal cancers, focusing on gastro-oesophageal adenocarcinoma and pancreatic cancer.
At MediMix, we are dedicated to keeping Belgian healthcare professionals at the forefront of medicine. Our team brings you high-value insights from leading congresses worldwide, across key disease areas including oncology. In collaboration with Belgian and international experts, we transform the latest data into practical knowledge.
Latest publications

Prof Jean-Luc Van Laethem reviews highlights from the ESMO 2026 Rapid Oral 1 session on upper gastrointestinal cancers, focusing on gastro-oesophageal adenocarcinoma and pancreatic cancer.

Following the rapid oral session on melanoma and skin cancer at ESMO 2026, Dr Celine Jacobs reviewed emerging therapeutic strategies for patients with advanced melanoma and high-risk cutaneous squamous cell

In this highlights video, Prof Dr Sebahat Ocak shares her selection of key findings from the rapid oral session on metastatic non-small cell lung cancer (NSCLC) at ESMO 2026 in

Dr Laetitia Collet summarised the rapid oral 1 session on gynaecological cancers, highlighting promising developments in ADCs for cervical cancer and novel targeted therapies for ovarian cancer patients with CCNE1

Prof Dr Francesco Sclafani shares his key takeaways from the proffered paper session on lower gastrointestinal cancers at ESMO 2026 in Madrid, where new evidence emerged on treatment intensification, recurrence
At MediMix, we are dedicated to keeping Belgian healthcare professionals at the forefront of medicine. Our team brings you high-value insights from leading congresses worldwide, across key disease areas including oncology. In collaboration with Belgian and international experts, we transform the latest data into practical knowledge.
Latest publications

Prof Jean-Luc Van Laethem reviews highlights from the ESMO 2026 Rapid Oral 1 session on upper gastrointestinal cancers, focusing on gastro-oesophageal adenocarcinoma and pancreatic cancer.

Following the rapid oral session on melanoma and skin cancer at ESMO 2026, Dr Celine Jacobs reviewed emerging therapeutic strategies for patients with advanced melanoma and high-risk cutaneous squamous cell

In this highlights video, Prof Dr Sebahat Ocak shares her selection of key findings from the rapid oral session on metastatic non-small cell lung cancer (NSCLC) at ESMO 2026 in

Dr Laetitia Collet summarised the rapid oral 1 session on gynaecological cancers, highlighting promising developments in ADCs for cervical cancer and novel targeted therapies for ovarian cancer patients with CCNE1

Prof Dr Francesco Sclafani shares his key takeaways from the proffered paper session on lower gastrointestinal cancers at ESMO 2026 in Madrid, where new evidence emerged on treatment intensification, recurrence
Donderdag 12 november 2026
Kontich
Gent
Linter
Onthaal vanaf 18 uur
Programma van 19 tot 22 uur
Kies jouw locatie en schrijf je in
Donderdag 12 november 2026
Kontich
Gent
Linter
Onthaal vanaf 18 uur
Programma van 19 tot 22 uur
Kies jouw locatie en schrijf je in